Bay, Laila T. http://orcid.org/0000-0002-0048-6093
Nielsen, Dorthe S. http://orcid.org/0000-0002-3954-7551
Flurey, Caroline http://orcid.org/0000-0002-7092-6170
Giraldi, Annamaria http://orcid.org/0000-0002-0033-8517
Möller, Sören http://orcid.org/0000-0003-0858-4269
Graugaard, Christian http://orcid.org/0000-0003-0217-3637
Ellingsen, Torkell http://orcid.org/0000-0003-0426-4962
Funding for this research was provided by:
Odense Universitetshospital (A2073)
KV Fonden (6034/65)
Gigtforeningen (A3814)
Odense University Hospital
Article History
Received: 13 December 2023
Accepted: 31 January 2024
First Online: 14 March 2024
Declarations
:
: AG receives consulting fees/honorarium from Futura Medical, Freya, and Pfizer, and for writing a manuscript from Pfizer, serves as a lecturer at Astellas, Pfizer, and Lundbeck, stocks Novo Nordisk, and provides expert testimony at Eli Lilly. All other authors declared no conflict of interest.
: The study was conducted according to relevant guidelines and regulations, and it was approved and registered by the Danish Data Protection Agency (case number: 2008-58-003) [CitationRef removed] and reported to The Danish Patient Safety Authority to obtain permission to collect data from medical records (case number: 3–3013-1445/1/), March 2016. No approval from the ethics committee was necessary according to Danish regulations.